{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:03:25Z","timestamp":1769753005860,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/nrclinonc.2009.48","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T10:31:07Z","timestamp":1243852267000},"page":"367-370","source":"Crossref","is-referenced-by-count":30,"title":["Breast cancer and pregnancy: how safe is trastuzumab?"],"prefix":"10.1038","volume":"6","author":[{"suffix":"Jr","given":"Hatem A.","family":"Azim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedro A.","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Liptrott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Catania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrclinonc200948_CR1","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000151362","volume":"74","author":"H Azim","year":"2008","unstructured":"Azim, H. & Azim, H. A. Jr Targeting Her-2\/neu in breast cancer: as easy as this! Oncology 74, 150\u2013157 (2008).","journal-title":"Oncology"},{"key":"BFnrclinonc200948_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM199003083221004","volume":"322","author":"GS Berkowitz","year":"1990","unstructured":"Berkowitz, G. S., Skovron, M. L., Lapinski, R. H. & Berkowitz, R. L. Delayed child-bearing and the outcome of pregnancy. N. Engl. J. Med. 322, 659\u2013664 (1990).","journal-title":"N. Engl. J. Med."},{"key":"BFnrclinonc200948_CR3","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJM199804163381607","volume":"338","author":"G Koren","year":"1998","unstructured":"Koren, G., Pastuszak, A. & Ito, S. Drugs in pregnancy. N. Engl. J. Med. 338, 1128\u20131137 (1998).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"BFnrclinonc200948_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000055399","volume":"61","author":"B Leyland-Jones","year":"2001","unstructured":"Leyland-Jones, B. Dose-scheduling\u2014Herceptin. Oncology 61 (Suppl. 2), 31\u201336 (2001).","journal-title":"Oncology"},{"key":"BFnrclinonc200948_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1097\/01.AOG.0000141570.31218.2b","volume":"105","author":"WJ Watson","year":"2005","unstructured":"Watson, W. J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet. Gynecol. 105, 642\u2013643 (2005).","journal-title":"Obstet. Gynecol."},{"key":"BFnrclinonc200948_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3816\/CBC.2005.n.040","volume":"6","author":"MA Fanale","year":"2005","unstructured":"Fanale, M. A., Uyei, A. R., Theriault, R. L., Adam, K. & Thompson, R. A. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin. Breast Cancer 6, 354\u2013356 (2005).","journal-title":"Clin. Breast Cancer"},{"key":"BFnrclinonc200948_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1200\/JCO.2005.04.6607","volume":"24","author":"AM Waterston","year":"2006","unstructured":"Waterston, A. M. & Graham, J. Effect of adjuvant trastuzumab on pregnancy. J. Clin. Oncol. 24, 321\u2013322 (2006).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc200948_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S1470-2045(06)71014-2","volume":"8","author":"AA Bader","year":"2007","unstructured":"Bader, A. A., Schlembach, D., Tamussino, K. F., Pristauz, G. & Petru, E. Anhydramnios associated with adminstration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol. 8, 79\u201381 (2007).","journal-title":"Lancet Oncol."},{"key":"BFnrclinonc200948_CR9","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.reprotox.2007.02.003","volume":"23","author":"A Shrim","year":"2007","unstructured":"Shrim, A., Garcia-Bournissen, F., Maxwell, C., Farine, D. & Koren, G. Favorable pregnancy outcome following Trastuzumab (Herceptin\u00ae) use during pregnancy. Case report and updated literature review. Reprod. Toxicol. 23, 611\u2013613 (2007).","journal-title":"Reprod. Toxicol."},{"key":"BFnrclinonc200948_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/01.AOG.0000267133.65430.44","volume":"110","author":"R Sekar","year":"2007","unstructured":"Sekar, R. & Stone, P. R. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet. Gynecol. 110, 507\u2013510 (2007).","journal-title":"Obstet. Gynecol."},{"key":"BFnrclinonc200948_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/annonc\/mdm542","volume":"19","author":"ID Witzel","year":"2008","unstructured":"Witzel I. D., M\u00fcller, V., Harps, E., Janicke, F. & Dewit, M. Trastuzumab is pregnancy associated with poor fetal outcome. Ann. Oncol. 19, 191\u2013192 (2008).","journal-title":"Ann. Oncol."},{"key":"BFnrclinonc200948_CR12","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.reprotox.2007.11.004","volume":"25","author":"P Berveiller","year":"2008","unstructured":"Berveiller, P., Mir, O., Sauvanet, E., Antoine, E. C. & Goldwasser, F. Ectopic pregnancy in a breast cancer patient receiving trastuzumab. Reprod. Toxicol. 25, 286\u2013288 (2008).","journal-title":"Reprod. Toxicol."},{"key":"BFnrclinonc200948_CR13","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1200\/JCO.2008.16.0309","volume":"26","author":"S Pant","year":"2008","unstructured":"Pant, S., Landon, M. B., Blumenfeld, M., Farrar, W. & Shapiro, C. L. Treatment of breast cancer with trastuzumab during pregnancy. J. Clin. Oncol. 26, 1567\u20131569 (2008).","journal-title":"J. Clin. Oncol."},{"key":"BFnrclinonc200948_CR14","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.reprotox.2008.02.002","volume":"25","author":"C Weber-Schoendorfer","year":"2008","unstructured":"Weber-Schoendorfer, C. & Schaefer, C. Trastuzumab exposure during pregnancy. Reprod. Toxicol. 25, 390\u2013391 (2008).","journal-title":"Reprod. Toxicol."},{"issue":"Suppl. 3","key":"BFnrclinonc200948_CR15","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.3816\/CBC.2008.s.007","volume":"8","author":"EA Perez","year":"2008","unstructured":"Perez, E. A. Cardiac toxicity of ErbB2-targeted therapies: what do we know? Clin. Breast Cancer 8 (Suppl. 3), S114\u2013S120 (2008).","journal-title":"Clin. Breast Cancer"},{"key":"BFnrclinonc200948_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","volume":"368","author":"K Sliwa","year":"2006","unstructured":"Sliwa, K., Fett, J. & Elkayam, U. Peripartum cardiomyopathy. Lancet 368, 687\u2013693 (2006).","journal-title":"Lancet"},{"key":"BFnrclinonc200948_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/rp.59.1.1","volume":"59","author":"A Negro","year":"2004","unstructured":"Negro, A., Brar, B. K. & Lee, K. F. Essential roles of Her2\/erbB2 is cardiac development and function. Recent Prog. Horm. Res. 59, 1\u201312 (2004).","journal-title":"Recent Prog. Horm. Res."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.48","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrclinonc.2009.48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:03:22Z","timestamp":1684469002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrclinonc.2009.48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFnrclinonc200948"],"URL":"https:\/\/doi.org\/10.1038\/nrclinonc.2009.48","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}